Last updated: May 29, 2026

Application No. 17/754,924

MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF

Final Rejection

Filed

Apr 15, 2022

Priority

Oct 15, 2019 — CN 201910975631.8 +1 more

Examiner

YOO, SUN JAE

Art Unit

1621

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Tianjin Normal University

OA Round

2 (Final)

Interview Optional

— +0.0% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 71% grant rate with +0.0% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 1227 resolved cases, 2023–2026

Examiner Intelligence

YOO, SUN JAE View full profile →

Grants 71% — above average

Career Allowance Rate

871 granted / 1227 resolved

+11.0% vs TC avg

Minimal +0% lift

Without

With

+0.0%

Interview Lift

resolved cases with interview

Typical timeline

2y 8m

Avg Prosecution

97 currently pending

Career history

1279

Total Applications

across all art units

Statute-Specific Performance

§101

0.7%

-39.3% vs TC avg

§103

20.1%

-19.9% vs TC avg

§102

27.4%

-12.6% vs TC avg

§112

24.1%

-15.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1227 resolved cases

Prosecution Timeline

Apr 15, 2022

Application Filed

Sep 18, 2025

Non-Final Rejection mailed

Dec 17, 2025

Response Filed

Apr 01, 2026

Final Rejection mailed

May 21, 2026

Applicant Interview (Telephonic)

May 21, 2026

Examiner Interview Summary

Precedent Cases

Applications granted by this same examiner with similar technology

17/907,174

Patent 12637455

NAPHTHYRIDINE AND PYRIDO[3,4-c]PYRIDAZINE DERIVATIVES AS GABAA ALPHA 5 RECEPTOR MODULATORS

3y 8m to grant Granted May 26, 2026

18/613,641

Patent 12636280

Therapeutic Tyrosine Kinase Inhibitors for Relapsing Multiple Sclerosis (RMS)

2y 2m to grant Granted May 26, 2026

18/289,437

Patent 12635400

ORGANOMETALLIC COMPOUND AND APPLICATION THEREOF

2y 6m to grant Granted May 19, 2026

17/771,344

Patent 12623997

Non-Coordinating Anion Activators Containing a Cation with Long Chain Alkoxy Functionalization

4y 0m to grant Granted May 12, 2026

18/006,068

Patent 12612377

PROCESS FOR PREPARING AMINOFURANES

3y 3m to grant Granted Apr 28, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

71%

Grant Probability

71%

With Interview (+0.0%)

2y 8m (~0m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 1227 resolved cases by this examiner. Grant probability derived from career allowance rate.